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State-Dependent Differences in Emotion Regulation Between
Unmedicated Bipolar Disorder andMajor Depressive Disorder
Maria M. Rive, MD; Roel J. T. Mocking, MSc; MaartenW. J. Koeter, PhD; Guido vanWingen, PhD;
Stella J. deWit, MD; Odile A. van den Heuvel, MD, PhD; Dick J. Veltman, MD, PhD;
Henricus G. Ruhé, MD, PhD; Aart H. Schene, MD, PhD
IMPORTANCE Major depressive disorder (MDD) and bipolar disorder (BD) are difficult to
distinguish clinically during the depressed or remitted states. Bothmood disorders are
characterized by emotion regulation disturbances; however, little is known about emotion
regulation differences betweenMDD and BD. Better insight into these differences would be
helpful for differentiation based on disorder-specific underlying pathophysiological
mechanisms. Previous studies comparing these disorders often allowedmedication use,
limiting generalizability and validity. Moreover, patients with MDD and BDweremostly
compared during the depressed, but not the remitted, state, while state might potentially
modulate differences betweenMDD and BD.
OBJECTIVE To investigate positive and negative emotion regulation in medication-free
patients with MDD and BD in 2mood states: depressed or remitted.
DESIGN, SETTING, AND PARTICIPANTS A cross-sectional study conducted fromMay 2009 to
August 2013 comparing behavioral and functional magnetic resonance imaging emotion
regulation data of 42 patients with MDD, 35 with BD, and 36 healthy control (HC) participants
free of psychotropic medication recruited from several psychiatric institutions across the
Netherlands.
INTERVENTION A voluntary emotion regulation functional magnetic resonance imaging task
using positive and negative pictures.
MAIN OUTCOMES ANDMEASURES Behavioral and functional magnetic resonance imaging
blood oxygen level–dependent responses during emotion regulation.
RESULTS In the remitted state, only patients with BD showed impaired emotion regulation
(t = 3.39; P < .001; Cohen d = 0.70), irrespective of emotion type and associated with
increased dorsolateral prefrontal cortex activity compared with those with MDD and healthy
control participants (P = .008). In the depressed state, patients with MDD and BD differed
with regard to happy vs sad emotion regulation (t = 4.19; P < .001; Cohen d = 1.66) associated
with differences in rostral anterior cingulate activity (P < .001). Patients with MDD regulated
sad and happy emotions poorly compared with those with BD and healthy control
participants, while they demonstrated no rostral anterior cingulate difference between happy
and sad emotion regulation. In contrast, patients with BD performedworse than those with
MDD on sad emotion regulation but normal on happy emotion regulation, and they
demonstrated significantly less rostral anterior cingulate activity while regulating happy
compared with sad emotions.
CONCLUSIONS AND RELEVANCE Medication-free patients withMDD vs BD appear to differ in
brain activations during emotion regulation, both while depressed and in remission. These
different neuropathophysiological mechanisms betweenMDD and BDmay be useful for
further development of additional diagnostic tools.
JAMA Psychiatry. 2015;72(7):687-696. doi:10.1001/jamapsychiatry.2015.0161
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D istinguishing between major depressive disorder(MDD) and bipolar disorder (BD) is important be-cause treatment strategies andprognosisdiffer.1-3 Cur-
rent diagnostic tools (questionnaires and clinical interviews)
poorly differentiate between MDD and BD4-6 during depres-
sion or remission, emphasizing the need for validated bio-
markers to facilitatediagnostic procedures. Better insight into
underlying neural mechanisms of both disorders may aid in
the development of such biomarkers.
Major depressive disorder and BD share disturbances in
emotion processing and regulation,7-10 reflected by func-
tional and structural frontolimbic alterations. Emotion regu-
lation refers to cortical control over limbic regions. More
automatic processes involve predominantly medial prefron-
tal cortical (PFC) structures, including the anterior cingulate
cortex (ACC), orbitofrontal cortex, and dorsomedial PFC, as
well as the (para)hippocampus. More voluntary processes
additionally recruit lateral prefrontal cortical regions (dor-
solateral PFC [DLPFC] and ventrolateral PFC [VLPFC]).11
Patients with MDD show lateral PFC hyperfunction or hypo-
function (during automatic or voluntary emotion regula-
tion, respectively), while BD is associated with VLPFC and
ventromedial PFC hypofunction. Furthermore, both disor-
ders are characterized by predominantly decreased fronto-
limbic connectivity.11-14
Direct comparisons of emotion processing and regulation
between MDD and BD are sparse14 and the results are incon-
clusive. Regarding emotion processing, in depressed patients
with BD (BDd) vs MDD (MDDd), both increased (eg, amyg-
dala, thalamus, and hippocampus)15,16 and decreased (eg,
insula and temporal cortex)17 activity in response to negative
and/or positive emotional stimuli were reported. Moreover,
Grotegerd et al18 found increased amygdala activity in
response to sad stimuli in MDDd but to happy stimuli in BDd,
whereas Fournier et al19 observed the reverse pattern.
Regarding emotion regulation, 2 studies found no differ-
ences in attentional control over positive or negative emo-
tional pictures between MDDd and BDd,20,21 whereas for
neutral pictures, patients with MDDd demonstrated greater
dorsal anterior cingulate activity than BDd.21 For cognitive
control over negative emotions, decreased VLPFC and dor-
somedial PFC activity in MDDd vs BDd was reported.22 One
study comparing remitted MDD (MDDr) and BD (BDr)
reported differential prefrontal activity patterns during
attentional control over happy, but not sad, emotional
stimuli.23
Theseconflicting findingsmaybeexplained,at leastpartly,
as resulting frommedication use in previous studies (except
as in the study by Cerullo et al20). Antidepressants andmood
stabilizers impactemotionregulation–relatedbrain regions (eg,
the amygdala andDLPFC).24-35 Consequently, differentmedi-
cation classes used for MDD and BD may have had differen-
tial effects on neural activity. Moreover, to further delineate
underlying neuropathophysiology, it is important to under-
stand whether differences between MDD and BD are state or
trait effects. However, studies comparing MDD and BD so far
havebeenconducted indepressedpatients only (except in the
study by Matsubara et al23).
To expand our knowledge of emotion regulation in MDD
andBDacrossmoodstateswithoutmedicationconfounds,we
investigated emotion regulation differences between medi-
cation-free patients with MDD and with BD, either in de-
pressed or remitted states, using a validated functional mag-
netic resonance imaging (fMRI)paradigmfeaturing reappraisal
of emotional pictures. Because earlier studies suggested that
negative and positive emotion regulationmaydiffer between
MDD and BD, we used positive and negative emotional
pictures.12,18,36-38 Present literature does not allow very spe-
cific hypotheses; however, given BD’s vulnerability for recur-
rent (hypo)manic episodes, we hypothesized that particu-
larly positive emotion regulationwoulddifferentiate between





MDD and BD-I/BD-II were recruited from several psychiatric
institutions across the Netherlands via general practitioners,
advertisements,patientorganizations, andother researchproj-
ects. For inclusion and exclusion criteria, see the eAppendix
in the Supplement.
This study, conducted fromMay2009 toAugust 2013,was
approved by the Academic Medical Center Medical Ethical
Committee. Patients participated after providing written in-
formed consent; they received €40 (US $43.41) and travel
expenses.
Demographics and Clinical Characteristics
Sixpatientswereexcludedbecauseofpooror incompletedata
(eAppendix in the Supplement). Major depressive disorder
(MDDr: n = 21;MDDd: n = 21) andBD (BDr: n = 26; BDd: n = 9)
were comparable regarding age, sex, education, IQ, age at ill-
nessonset, illnessduration, andcomorbidanxiety (allP > .05).
Hamilton Depression Rating Scale39,40 scores differed be-
tween depressed and remitted patients (P < .001) but not be-
tween MDD and BD within the remitted/depressed groups
(P > .05). The number of previous major depressive episodes
was higher in BDd vs MDDd (P = .02) (Table 1). Healthy con-
trol (HC) individuals (n = 36) were comparable with patients
regarding age, sex, education, and IQ (P > .05).
Emotion Regulation Paradigm
Similar to previous emotion regulation studies,41-47 patients
viewedpictures of different emotional categories (sad, happy,
fearful, andneutral) (eTable 1 in the Supplement) andwere in-
structed to passively experience (attend condition) or ac-
tively regulate through distancing (regulate condition) any
emotion elicited (see eFigure 1, eTable 2, and the eAppendix
in the Supplement for details). Distancing, rather than situa-
tion-focused reappraisal, was chosen as the regulation
strategy48 because distancing was easier to apply for de-
pressed patients. Distancing involves the process of becom-
ing a detached observer by thoughts such as: “This is only a
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Table 1. Demographic and Clinical Characteristicsa
Characteristic










(n = 9) F/χ2 P Value t/χ2 P Value t/χ2 P Value
Age 40.2 (10.8) 42.0 (10.4) 42.7 (10.7) 44.0 (8.9) 40.1 (10.9) 0.56 .69 0.24 .81 0.94 .35
Sex
Male 11 8 10 6 4
1.27 .87 0.01 .98 0.71 .40
Female 25 13 16 15 5
Educationb
Low 1 2 2 3 0
12.33 .14 0.23 .89 1.74 .41Middle 6 7 7 10 4
High 29 12 16 8 5
No. of previous MDEs,
median (range)c
0 4.0 (2-20) 6.5 (2-20)d 3.0 (2-20) 10 (3-20) … <.001 … .21e … .006e
IQ 105.0 (13.1) 101.7 (9.8) 101.5 (9.5) 96.8 (16.5) 102.0 (12.1) 1.41 .23 0.07 .95 0.95 .35
Age at illness onset, y … 23.5 (9.4) 23.6 (8.7) 25.5 (8.4) 20.8 (8.4) 0.64 .59 0.02 .98 1.36 .18
Duration of illness, y … 19.9 (10.8) 19.2 (10.5) 17.9 (10.1) 19.6 (12.7) 0.14 .94 0.23 .82 0.40 .69
HDRS scoref 1.3 (1.7) 6.3 (5.2) 5.5 (5.5) 21.6 (5.4) 22.8 (7.1) 87.10 <.001 0.57 .57 0.62 .54
Comorbid anxiety
disorderg
0 3 2 3 2 1.39 .71 0.53 .47 0.29 .59




1-3 … 4 6 4 2
7.0 .34 5.51 .09 0.31 >.99>3-12 … 1 9 2 2
>12 … 8 6 7 4
Duration of remissioni
1 wk-3 mo … 7 7 … …
… … 2.07 .39 … …>3-12 mo … 4 10 … …
>12 mo … 7 6 … …
History of substance
use disorder




3-6 … 0 4j 0 1
4.52 .26 1.98 .28 2.25 .33
>6 … 4 7 6 2
Current substance
usek
Alcohol 31 14 20 13 8 5.86 .21 0.60 .50 2.18 .21
Tobacco 7 5 9 7 4 3.97 .43 0.77 .52 0.34 .69
Drugs (incidental) 4 1 4 0 0 4.97 .30 1.26 .37 … …
Benzodiazepine use,
No.
… 0 1l 1m 1n 2.15 .84 0.83 >.99 0.41 >.99
Abbreviations: BDd, bipolar disorder depressed state; BDr, bipolar disorder
remitted state; HDRS, Hamilton Depression Rating Scale; HC, healthy control;
IQ, intelligence quotient; MDDd, major depressive disorder depressed state;
MDEs, major depressive episodes; MDDr, major depressive disorder remitted
state; ellipses, not applicable.
a Within the depressed and remitted groups, there were no significant
differences betweenMDD and BD regarding demographic or clinical
characteristics, except for the number of previous episodes. The boldface type
indicates a significant result, corrected for multiple testing.
b Low: primary education or preparatory middle-level applied education;
middle: higher general continued education or middle-level applied education;
and high: preparatory scientific education, higher applied education, or
scientific education.
c More than 20 episodes are set on 20 episodes.
d Threemissing values.
e Kruskall-Wallis test comparing medians.
f 17-ItemHDRS.
g Hypochondria, specific phobia, social phobia, panic disorder, and
obsessive-compulsive disorder.
hMissing values: 3 for MDDr, 3 for BDr, and 2 for MDDd; all patients were at least
1 month free of medication.
i Missing values: 3 for MDDr and 3 for BDr.
j Missing values: 2 for BDr.
k Alcohol/cannabis abuse/dependence until 5 to 6months before scanning.
l Lorazepam, 2.5 mg; quit 17 hours before scanning.
mOxazepam, 25mg; quit 48 hours before scanning.
n Temazepam, 20mg; quit 40 hours before scanning.
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picture,” “This has nothing to dowithme,” and “This picture
is fake.” Incontrast, situation-focusedreappraisal requiresmore
complicated cognitiveprocesses: patientsneed to reframe the
situation depicted in such away that themeaning of the situ-
ation becomesmore neutral (eg, when people are shown cry-
ing, one could think, “They are crying for joy, not sadness”).48
After the scan, patients judged all pictures on valence,
arousal, and emotional intensity of 5 basic emotions (sad-
ness, fear, disgust, anger, andhappiness) (eTable 3 andeTable
4 in the Supplement). This task was included to assess pos-
sible between-group differences in baseline emotional ap-
praisal of pictures because these might influence regulation




scanner (Philips Intera, Philips Medical Systems) with an
8-channel SENSE head coil (eAppendix in the Supplement).
Analyses
Behavioral Data
To assess differences in emotion regulation success between
MDDandBD,we calculated in-scan regulation success scores
for each emotion by expressing the difference betweenmean
emotional intensities (attendingminus regulating) as theper-
centageof themeanemotional intensityduringattending.Neu-
tral pictures were not regulated and therefore not used to as-
sessbetween-groupemotionregulationdifferences.Regulation
success scores were arcsine transformed to meet normality
assumptions.
To assess diagnosis and state and emotion effects, a regu-
lation success score was entered as a dependent variable in a
linearmixedmodel regressionanalysis (IBMSPSSStatisticsver-
sion 20), with diagnosis (MDD/BD), state (depressed/
remitted), andemotion (sad/fear/happy) as independent vari-
ables.ThesignificancethresholdwassetatP < .003 (Bonferroni
corrected for 16 post hoc tests). Significant main effects were
followedupwith post hoc tests. BecauseHC individualswere
only euthymic andwe primarily investigatedMDD/BDdiffer-
ences, HC individuals were not included in thismodel. To as-
sess whether thosewithMDD and/or BD differed fromHC in-
dividuals,we compared either remittedor depressedpatients
withMDDandBDwithHC individuals in separatemixedmod-
els. Further details regarding behavioral data are in the eAp-
pendix in the Supplement.
Functional MRI Data
Statistical parametric mapping (SPM; http://www.fil.ion.ucl
.ac.uk/spm/software/spm8/) was used for fMRI data analysis
(eAppendix in the Supplement).
Main effects for task were assessed by calculating indi-
vidual statistical maps for attend emotion greater than at-
tend neutral and regulate emotion greater than attend emo-
tion and feeding these into second-level 1-sample t tests.
For assessment of blood oxygen level–dependent activity
differences between MDD and BD, contrasts of interest were
based on behavioral results (see further on), indicating that
MDDr and BDr differed regarding overall emotion regulation,
irrespective of emotion type (regulate emotion > attendemo-
tion), andMDDdandBDddiffered regardinghappyvssademo-
tion regulation (regulate happy > attend happy)>(regulate
sad > attend sad). These contrasts were entered into second-
level random effects analyses using 1-way analyses of vari-
ance. We additionally report a 2 × 2 factorial design for each
contrast to test for diagnosis-by-state interactions (eAppen-
dix in the Supplement).
We studied 7 regions of interest (ROIs)38,41,42,44,48: the
amygdala, thalamus, insula,DLPFC(Brodmannarea9/46),ACC,
medial PFC (Brodmann area 8), and hippocampus.We report
results surviving family-wise error, small-volume correction
for bilateral anatomical ROIs (WFU Pickatlas version 2.449,50)
or surviving whole-brain family-wise error correction. We
applied Bonferroni correction to account for the number of
ROIs, adjusted for the mean correlation (r = 0.18) between
ROIs, rendering an equivalent corrected α of .01 (http://www
.quantitativeskills.com/sisa/calculations/bonfer.htm). Theef-
fects of task performance on task-related blood oxygen level–
dependent activity were assessed with correlation analyses




tion (F = 5.25;P = .006) (Figure 1; eTable 5 in the Supplement).
In the remitted group, there were no diagnosis-by-
emotion interactions (all P ≥ .80; Figure 1A). Therefore, we
compared regulation success scores between MDDr and BDr
across emotions. PatientswithBDrwere significantly less suc-
cessful in emotion regulation than thosewithMDDr (t = 3.39;
P < .001; Cohend = 0.70).OnlyBDrdiffered significantly from
HC individuals (t = 4.64; P < .001; d = 0.94).
In the depressed group (Figure 1B), therewas a significant
effectofdiagnosisonthedifference inregulationsuccessscores
between happy vs sad emotions (t = 3.86; P < .001): patients
with BDd, but notMDDd, showed significantly stronger regu-
lationofhappycomparedwithsademotions (t = 4.19;P < .001;
d = 1.66). Therewere no significant effects of diagnosis on the
differences in regulation success scores for fear (all P ≥ .02).
PatientswithMDDdwere less successful regulatinghappy
emotions than HC individuals (t = 3.045; P = .003; d = 0.85),
whereas thosewith BDdwere trendwise less successful regu-
lating sad emotions than HC individuals (t = 2.77; P = .006;
d = 0.6), with a trendwise diagnosis (HC individuals vs BDd)–
by–emotion (happy vs sad) interaction (t = 2.92; P = .004).
Functional MRI Data
Main Task Effects
Both attend emotion greater than attendneutral and regulate
emotiongreater thanattendemotionwere associatedwithex-
pectedregionalbrainactivity (ie, limbic regions forattendemo-
tion > attend neutral and regulatory regions [supplementary
motor area and medial frontal cortex] for regulate > attend)
(eFigure 2 and eTable 6 in the Supplement).
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Remitted State and Regulation Across Emotions
Behavioraldata showedthatMDDrandBDr,butnotMDDdand
BDd, differed regarding overall emotion regulation (Table 2;
Figure 2A). Testing this in the fMRI data using planned com-
parisons showed a significant difference in DLPFC (inferior
frontal gyrusand inferior frontal gyrus) activitybetweenMDDr
and BDr for regulate emotion greater than attend emotion
(greater in BDr), collapsed over all emotions (P = .008). This
effect was not observed in MDDd and BDd, corresponding to
the behavioral results. The 2 × 2 factorial design additionally
revealed a diagnosis-by-state interaction in the inferior fron-
tal gyrus (uncorrected P < .001; eTable 7 in the Supplement);
this interaction did not survive multiple comparison correc-
tion (eAppendix in the Supplement).
Therewerenodifferences inDLPFCactivitybetweenthose
with MDDr or BDr and HC individuals.
Depressed State and Regulation of Sad vs Happy Emotions
Behavioral data indicated thatMDDd and BDd, but notMDDr
andBDr, differed regarding happy vs sad emotion regulation.
Comparing (regulatehappy > attendhappy)>(regulatesad > at-
tend sad) inMDDd vs BDd revealed a significant difference in
rostral ACC (rACC) activity (P < .001) (Table 2; Figure 2B). In
BDd, we found a decrease in rACC activity during regulation
of happy emotions and an increase during regulation of sad
emotions,whichwereabsent inMDDd. Inaccordancewithbe-
havioral results, this effectwasnotobserved inMDDrandBDr.
The 2 × 2 factorial design furthermore revealed a diagnosis-
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There was a significant diagnosis-by-state-by-emotion interaction (F = 5.25;
P = .006) explained by the following pattern: A, Across all emotions, remitted
patients with bipolar disorder (BDr) (n = 26) performed significantly worse on
emotion regulation compared with both remitted patients with major
depressive disorder (MDDr) (n = 21; footnote b) and healthy control (HC)
individuals (n = 36; footnote a). There were no differences between depressed
patients with MDD (MDDd) and BD (BDd) on overall emotion regulation. B,
When emotions were separated, there was a significant diagnosis-by-(happy vs
sad) emotion regulation interaction in the depressed group (footnote d):
depressed patients with BD (n = 9) regulated happy emotions better than sad
emotions (footnote e), whereas depressed patients with MDD (n = 21) and HC
individuals (n = 36) showed no difference between happy and sad emotion
regulation success scores. Furthermore, there was a trendwise significant
diagnosis (HC vs BDd)-by-emotion (happy vs sad) interaction (footnote c).
There were no significant emotion-specific differences between remitted
patients with MDD and BD. The solid lines above the bars indicate a difference
between 2means and the dashed lines indicate an interaction effect. Error bars
represent 95% CIs.
a t = 4.64; P < .001; significant difference.
b t = 3.39; P < .001; significant difference.
c t = 2.92; P = .004, trendwise significant interaction.
d t = 3.86; P < .001; significant interaction.
e t = 4.19; P < .001; significant difference.
Table 2. Activity Differences for Regulate Greater Than Attend BetweenMDD and BDa
Comparison Area Side Cluster Size
Peak Voxel (MNI), mm
tx y z
Across Emotions, MDDr vs BDr
MDDr>BDr None … … … … … …
BDr>MDDr Inferior frontal gyrus, pars triangularis/
opercularis (BA 46)b
Right 27 40 16 34 4.63
Happy>Sad, MDDd vs BDd
MDDd>BDd Rostral anterior cingulate cortex (BA 32) Right 61 10 36 6 5.05
BDd>MDDd None … … … … … …
Abbreviations: BA, Brodmann area; BD, bipolar disorder; BDd, bipolar disorder
depressed state; BDr, bipolar disorder remitted state; MDD, major depressive
disorder; MDDd, major depressive disorder depressed state; MDDr, major
depressive disorder remitted state; MNI, Montreal Neurological Institute;
ellipses, not applicable.
a Results are significant at P < .009, family-wise error corrected for the bilateral
anatomical regions on interest.
bAlso significant at P < .05, family-wise error corrected across the whole brain
(k = 2; t = 5.41).
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by-state interaction in the rACC (uncorrectedP < .001; eTable
7 in the Supplement); this interaction did not survive mul-
tiple comparison correction (eAppendix in the Supplement).
Compared with HC individuals, patients with BDd dem-
onstrated nonsignificantly lower rACC activity for (regulate
happy > attendhappy)>(regulate sad > attend sad) (P = .049).
Adjustment for Previous Episodes
Results did not change after adjusting for the number of previ-
ousmajor depressive episodes (eTable 8 in the Supplement).
Correlation Analysis
Therewereno correlations between regulation success scores
and DLPFC or rACC activity.
Discussion
This fMRI study indicates that medication-free patients with
MDDandBDdiffer regardingemotionregulation,andthat these
differences aremood state dependent. During remission, BDr
butnotMDDr,showedimpairedemotionregulationacrossemo-
tions. During depression, MDDd and BDd differed regarding
happyvssademotionregulation:BDdshowedimpairedsad,but
unexpectedly normal happy, emotion regulation, whereas in
MDDd, both sad and happy emotion regulation were compro-
mised. These emotion regulation difficulties were associated
with DLPFC and rACC activity. Both regions have been impli-
cated in the specific regulation strategy we applied (dis-
tancing).11,51-53 TheDLPFC is thought to be involved in effortful
modulation of limbic regions, operating indirectly by feedback
via the orbitofrontal cortex.11 The rACCmayoperate via a feed-
forward mechanism and is involved in the evaluation of emo-
tionalandmotivational information,automaticredirectionofat-
tention away from emotional stimuli, emotional conflict
resolution,andemotionalexpression.11,53-55Wediscussthefind-
ings for remitted and depressed patients separately.
RemittedMDD vs BD
Whereas taskperformancewas similar in thosewithMDDrand
HC individuals, those with BDr performed worse on overall
emotion regulation,whichwas associatedwithgreaterDLPFC
activity. This suggests that increased DLPFC activity reflects
increased, but still insufficient, regulation attempts in BDr,
whichmay also explain the lack of significant correlations be-
tween DLPFC activity and regulation success.
Figure 2. Regional Activity Differences AssociatedWith Differences in Emotion Regulation Success
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A, Across emotions, remitted patients
with bipolar disorder (BDr)
demonstrated significant greater
dorsolateral prefrontal cortex activity
than remittedmajor depressive
disorder (MDDr) (footnote a).
Compared with healthy control (HC)
individuals, differences were not
significant. B, In contrast to
depressed patients with MDD
(MDDd), those with BP (BDd)
demonstrated a decrease in rostral
anterior cingulate cortex (rACC)
activity during regulation of happy
emotions and an increase in rACC
activity during regulation of sad
emotions (footnote b). Compared
with HC individuals, only those with
BDd differed (trendwise) significantly
(k = 43; t = 4.42; P = .015,
small-volume corrected for a bilateral
ACC region of interest). IFG indicates
inferior frontal gyrus.
a k = 31; t = 4.83; P = .006,
Small-volume corrected for bilateral
Brodmann area 9/46 region of
interest.
b k = 48; t = 4.79; P = .004,
Small-volume corrected for a
bilateral ACC region of interest.
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Our finding contrasts with decreased DLPFC and VLPFC
activity in BDr reported previously,42 perhaps owing to differ-
ent reappraisal strategies (situation focused vs self-focused),
which have been associated with different prefrontal cortical
regions.48 Nevertheless, increased DLPFC activity in BDr has
also been demonstrated with other emotion regulation
tasks.56-58
InMDDr,emotionregulationwasapparentlynormal, in line
with previous behavioral studies.59 However, Kanske et al59
demonstrated altered orbitofrontal cortex and amygdala ac-
tivity suggestive of sustained emotion regulation abnormali-
ties inMDDr, albeitwithsituation-focusedreappraisal.Wesug-
gest that distancing may have been easier to apply for our
patients with MDDr than the more complicated situation-
focusedreappraisal, suggesting thatemotion regulationbydis-
tancing may differentiate MDDr from BDr.
DepressedMDD vs BD
Both MDDd and BDd differed regarding happy vs sad emo-
tion regulation.However, theperformanceof thosewithMDD
and BDwas discordant with our expectation: those with BDd
showed normal performance on happy, but not on sad, emo-
tion regulation,whereas thosewithMDDdperformedequally
poorly on both sad and happy emotion regulation.
Importantly, postscan ratingsof emotional intensityof sad
and happy pictures (eAppendix in the Supplement) revealed
that patients withMDDd perceived sad pictures less negative
and happy pictures less positive than those with BDd (ie, rat-
ings for negative/positive valence were less extreme in those
with MDDd than in those with BDd) (eTable 3 in the Supple-
ment). Also, experiencinghappiness in response tohappypic-
tureswasmixedwithsadness inMDDd(eTable4 in theSupple-
ment).Therefore,patientswithMDDdmaynothavebeen fully
capableofexperiencingpositiveemotions in response tohappy
pictures, in agreementwith the emotional context insensitiv-
ity hypothesis in MDD (ie, blunted general emotional
experience).60 Incontrast, suchbluntingwasnotpresent inour
BDd sample, in line with previous findings in BD of ex-
tremelynegative, but also extremelypositive, appraisals of in-
ternal states,61 increased rumination in response to negative
and positive affect,62 and increased limbic activity in re-
sponse to both negative and positive emotional faces.16
Thedifference inappraisal ofpositiveemotionsmaypartly
explain the discrepancy in behavioral regulation success be-
tweenMDDdandBDd. Speculatively,wepropose that inBDd,
happypicturesevokedhappyandthusmoodincongruentemo-
tions, forwhichdistancing isprobablyeasy,whereas inMDDd,
happy pictures also evoked mood congruent (ie, sad) emo-
tions, forwhichdistancing ismoredifficult. Indeed, inMDDd,
sad intensity of happy pictures correlated (trendwise signifi-
cantly) negativelywith regulation success (τ = −0.28; P = .07;
eFigure 3 in the Supplement), indicating more difficult regu-
lation for sad emotions elicited by these happy pictures.
The difference in appraisal of positive emotionsmay also
partlyexplain thedisparity in rACCactivitybetweenMDDdand
BDd, which may reflect differences in emotional conflict
experience.63 Regulation of mood congruent emotions (de-
creasing emotions in accordance with mood state) may cre-
ateanemotional conflict andhenceactivate the rACC,whereas
regulation of mood incongruent emotions (decreasing emo-
tions discordant with mood state) may deactivate the rACC.
Therefore, in BDd, regulation of positive emotions elicited by
happy picturesmay have resolved emotional conflict, deacti-
vating the rACC (Figure 2B), whereas regulation of negative
emotions (sad pictures) created emotional conflicts, activat-
ing the rACC. In those with MDDd, emotions were less in-
tense; hence, emotional conflict experience may have been
subdued, leaving rACC reactivity virtually absent (eFigure 4
in the Supplement).
Possible Implications for Differences in Treatment Response
and Prognosis
Dysfunctional DLPFC-rACC interaction is thought to inter-
ferewithnormal reductionof rACCandamygdala activitydur-
ing cognitive or emotional challenges and thus with ad-
equate cognitive control of emotion, leading to maladaptive
rumination and eventually treatment resistance.55 Our re-
sults of increasedDLPFC activity and increased rACC reactiv-
ity in BD vs MDD may indicate qualitatively different fron-
tocingulate dysregulation in BD, which, tentatively, may
explain why BD generally responds less well to antide-
pressants64 or cognitive behavioral therapy.65 Furthermore,
whereas patientswithMDDr resembledHC individuals, those
with BDr demonstrated behavioral emotion regulation im-
pairments despite DLPFC hyperactivity, suggesting residual
neuropsychological and neural deficits, which may increase
relapse vulnerability. Moreover, compensatory frontal activ-
ity displayed by patients with BDr may deplete cognitive re-
sources, leading to cognitive impairments,55,66 which conse-
quentlymaynegatively impactdaily functioning, recovery,and
antidepressant treatment.67-71 Thus, our findings of in-
creased DLPFC activity in BDr, but not in MDDr, and qualita-
tive differences in frontocingulate dysfunction correspond to
the observation that patients with BD usually have a worse
prognosis than those with MDD.
Limitations and Strengths
Some limitations should be considered. First, theBDd sample
size was small, limiting statistical power. However, we still
foundbehavioral andneuralactivitydifferencesbetweenthose
with BDd vs with MDDd and HC individuals, indicating ro-
bust effects. Second, we included only recurrent MDD, so re-
sults cannot be extrapolated to single-episode MDD. How-
ever, given the recurrent nature of BD, this choice likely
enhancesoverallvalidityof thestudy.Third,owingtoourcross-
sectional designwe could not establishwhetherMDD/BDdif-
ferences result from a preexisting vulnerability to specifi-
cally develop either mood disorder or from scarring due to
previous (hypo)manic episodes in BD. Fourth, our MDD and
BD samplesmay not fully represent theMDD and BD popula-
tion because patients were able to manage without medica-
tion, at least for a certain period. However, comparing these
possibly less severe MDD/BD samples may, if anything, have
reduced the likelihood of detecting MDD vs BD differences.
Fifth, a trendwise (P = .06) greater proportionof patientswith
BD than with MDD had a history of substance (predomi-
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nantly alcohol) use disorder. Because in most cases the sub-
stanceuse disorder concerned abuse rather thandependence
and was in remission for more than a year, a substantial im-
pact on our results appears unlikely.
The strengths of our study were the inclusion of medica-
tion-free patients, excluding the possibility thatMDD/BDdif-
ferences weremediated by differentmedication classes. Sec-
ond, by inclusion of depressed and remitted patients, we
demonstrated state-by-diagnosis interactions, revealing state-
specific differences between BD and MDD. Third, by select-
ingonly thosewithMDDwithanegativeBD familyhistoryand
an illness duration of 5 years or more, we reduced the risk of
including patients with latent BD in the MDD group.
Conclusions
This study demonstrated that medication-free remitted pa-
tientswithMDDandBDdiffer regardingoverall emotion regu-
lation associatedwith differences in DLPFC activity, whereas
medication-free depressed patients with MDD and BD differ
regardinghappyvs sademotion regulationassociatedwithdif-
ferences in emotional appraisal and rACC activity. These re-
sults corroborate previous findings indicating that during de-
pression,MDDandBDmaydifferparticularly regardinghappy
vs sad emotion processing/regulation. Furthermore, emo-
tion regulation impairments in BD, but notMDD, appear to be
still present during remission. These state-specific emotion
regulation differences may represent different underlying
pathophysiological mechanisms, whichmay be useful for in-
dividual classification of patients with MDD and BD. Eventu-
ally, such investigations may be incorporated in a hierarchi-
cal diagnostic pipeline formooddisorders, combining clinical
characteristics (such as DSM-5 criteria) with additional neu-
ropsychological investigations and, for example, imagingbio-
markers to resolve remaining diagnostic uncertainty. Future
studies should assess this possibility inmedication-naive pa-
tients with different levels of depression severity.
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